IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Ibuprofen And Diphenhydramine Hydrochloride, and when can generic versions of Ibuprofen And Diphenhydramine Hydrochloride launch?
Ibuprofen And Diphenhydramine Hydrochloride is a drug marketed by Aurobindo Pharma Ltd, Bionpharma, and Strides Pharma. and is included in three NDAs.
The generic ingredient in IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE is diphenhydramine hydrochloride; ibuprofen. There are twenty-three drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the diphenhydramine hydrochloride; ibuprofen profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE?
- What are the global sales for IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE?
- What is Average Wholesale Price for IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE?
Summary for IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE
| US Patents: | 0 |
| Applicants: | 3 |
| NDAs: | 3 |
| Finished Product Suppliers / Packagers: | 16 |
| Clinical Trials: | 12 |
| DailyMed Link: | IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE at DailyMed |
Recent Clinical Trials for IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Overseas Pharmaceuticals, Ltd. | Phase 1 |
| Guangzhou Kangqi Medical Technology Co., LTD | Phase 1 |
| HALEON | Phase 1 |
See all IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE clinical trials
Pharmacology for IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE
| Drug Class | Histamine-1 Receptor Antagonist Nonsteroidal Anti-inflammatory Drug |
| Mechanism of Action | Cyclooxygenase Inhibitors Histamine H1 Receptor Antagonists |
US Patents and Regulatory Information for IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE | diphenhydramine hydrochloride; ibuprofen | CAPSULE;ORAL | 210676-001 | Feb 14, 2019 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Bionpharma | IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE | diphenhydramine hydrochloride; ibuprofen | CAPSULE;ORAL | 090397-001 | Nov 22, 2010 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Strides Pharma | IBUPROFEN AND DIPHENHYDRAMINE HYDROCHLORIDE | diphenhydramine hydrochloride; ibuprofen | CAPSULE;ORAL | 200888-001 | Mar 5, 2012 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
